My goal is to provide high-quality, evidence-based care while fostering collaborative relationships with my patients. Ms. Grace Thompson Bell is a board-certified nurse practitioner specializing in oncology andhematology. She graduated from Emory University’s nurse practitioner program and holds dualcertifications in adult-gerontology acute care and adult-gerontology primary care.Ms. Thompson Bell has experience in both academic and community oncology settings. Shepreviously practiced at Emory University’s Winship Cancer Institute in Atlanta, treatinghematologic conditions in both hospital and outpatient clinic environments. She also providedcomprehensive oncologic care at Suburban Hematology Oncology Associates, a communityoncology practice in the Atlanta suburbs.Ms. Thompson Bell remains actively involved with the Emory School of Nursing, serving as aguest lecturer.Ms. Thompson Bell treats a wide variety of oncologic and hematologic conditions including solid tumor malignancies, hematologic malignancies and benign hematologic disorders.Ms. Thompson Bell is a Central Coast native, raised in Arroyo Grande. After spending 10 years inAtlanta, she is excited to be back and looks forward to giving back to the community she calls home. Ms. Bell is rated as an Experienced provider by MediFind in the treatment of Thalassemia. Her top areas of expertise are Febrile Neutropenia, Thrombocytopenia, Chronic Familial Neutropenia, and Agranulocytosis.

Board Certification:Oncology & HematologyFellowship Training:Oncology & Hematology from University California DavisInternal Medicine Residency:Cornell UniversityMedical School:Institute of Medicine I, Ragoon, BurmaEducation:Masters of Public Health and Tropical Medicine Tulane UniversityAreas of Interest: Benign Hematology, Breast Cancer, Gastrointestinal Malignancies, Lung Cancer, Solid Tumors. Dr. Soe is rated as an Experienced provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Dr. Gorgun Akpek (Dr. G) is a board certified hematologist and medical oncologist who treats his patients with all types of cancer and blood related.Dr. Akpek received his MD degree from Hacettepe University, the top medical school in Turkey and did his internal medicine residency and hematology & medical oncology clinical fellowship trainings at Hacettepe University and Boston University Medical Centers. He became further specialized in Leukemia and Stem Cell/Bone Marrow Transplantation at Johns Hopkins University Department of Oncology in Baltimore, Maryland.He joined the faculty first at Johns Hopkins University and then University of Maryland Greenebaum Cancer Center as a clinical investigator and attending physician.He continued his career as a founding Director of Leukemia and Stem Cell Transplantation/Cell Therapy programs at Banner MD Anderson Cancer Center in Gilbert, Arizona and more recently he served as the Section Chief of Blood and Marrow Transplant Program (BMT) at Rush University Medical Center in Chicago.Dr. Akpek is a member of American Society of Hematology (ASH), Clinical Oncology (ASCO) and Transplantation (ASBMT). He is nationally recognized for his research by more than 100 publications and clinical work in leukemia, lymphoma, MDS, multiple myeloma and stem cell transplantation.Board Certification:Oncology, Hematology, Internal MedicineMedical School:Hacettepe University School of MedicineInternal Medicine Residency:Hacettepe University School of MedicineFellowship Training:Hacettepe University School of Medicine, Boston University Medical Center and Johns Hopkins UniversityAreas of Interest:All Cancers including: Autoimmune Cancer, Lung Cancer, Breast Cancer, Colon Cancer, Rectal Cancer,  Pancreatic Cancer, Gallbladder Cancer, Bladder Cancer, Ovarian Cancer, MelanomaAdditional Education: Master of Public Health, Johns Hopkins Bloomberg School of Public Health 2005. Awards and Recognition: Chief's Hematology and Oncology Scholar Award, Boston University 1995-1997 Jo-Ann McCaleb Amyloid Research Award 1997 Henry Christian Award, American Federation of Medical Research 2002. Dr. Akpek is rated as an Experienced provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Multiple Myeloma, Myelodysplastic Syndrome (MDS), Childhood Iron Deficiency Anemia, Bone Marrow Transplant, and Splenectomy.

Brian Dicarlo is an Oncologist in San Luis Obispo, California. Dr. Dicarlo is rated as an Experienced provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Familial Pancreatic Cancer, Paget Disease of the Breast, Lung Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Dicarlo is currently accepting new patients.

Dr. Keith Ayrons grew up on Long Island, New York, and completed his bachelor’s degree in Biology at the University of Albany while volunteering at the local hospital in the Pathology department. His passion for science and early learnings in the experimental and clinical based approach inspired him to complete first, a Master’s in Microbiology from Adelphi University and then his medical degree from Wayne State University. He then completed his Internal Medicine residency, and combined fellowship in Oncology and Hematology at Stoney Brook University. In 1995, Dr. Ayrons joined a growing oncology and hematology practice in Gastonia, North Carolina, where he was a partner for 23 years. He is Board Certified in Medical Oncology, Hematology and Internal Medicine and served as past president of the Internal Medicine department. For 25 years he developed excellent patient and family relationship skills that created a loyal patient following. In 2018, Dr. Ayrons relocated to the Central Coast and is excited to be a part of the Mission Hope Cancer Center where he can continue to fulfill his passion of serving the community through providing quality care. Dr. Ayrons is rated as an Advanced provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Familial Colorectal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Paget Disease of the Breast.